Quarterly ResultMay 18, 2026, 08:01 AM
BIO-key Q1 Revenue +34% to $2.15M; Net Loss Improves to $(165K)
AI Summary
BIO-key International reported a 34% increase in Q1'26 revenues to $2.15 million, with net loss significantly improving to $(165K) from $(737K) in Q1'25. The company projects strong growth and profitability for the first half of 2026, with Q2 revenues expected to rise 65% to approximately $2.8 million and 1H'26 revenues reaching $5 million. Key business achievements include a $1.04 million license renewal, new partnerships in Mozambique and the U.S. public sector, and exceeding $2 million in military/defense sales.
Key Highlights
- Q1'26 revenues increased 34% to $2.15M from $1.61M in Q1'25.
- Q1'26 net loss improved to $(165K) from $(737K) in Q1'25.
- Q2'26 revenues expected to rise 65% to approx. $2.8M.
- 1H'26 revenues expected to rise 50% to approx. $5M.
- Expects H1'26 profitability, improving from $(1.9M) net loss in H1'25.
- Secured $1.04M one-year biometric identity license renewal with a foreign bank.
- Surpassed $2M in military/defense sales over the latest twelve months.
- Q1'26 gross margin was 82.5%.
Price Impact
More from BKYI